ARTICLE | Clinical News
Bio-Technology General regulatory update
September 6, 1994 7:00 AM UTC
BTGC's BioLon received marketing approval in France for use in ophthalmic procedures. BioLon is a syringe containing a 1 percent solution of sodium hyaluronate. The Iselin, N.J., company said the the ...